The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients

PURPOSE: The occurrence pattern of immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. MATERIALS AND METHODS: Phase II–III clinical trials that evaluated ICI-based treatments in cancer and were published between January 2007 and Dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Si-Qi, Tang, Ling-Long, Mao, Yan-Ping, Li, Wen-Fei, Chen, Lei, Zhang, Yuan, Guo, Ying, Liu, Qing, Sun, Ying, Xu, Cheng, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053869/
https://www.ncbi.nlm.nih.gov/pubmed/33171025
http://dx.doi.org/10.4143/crt.2020.790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053869/
https://www.ncbi.nlm.nih.gov/pubmed/33171025
http://dx.doi.org/10.4143/crt.2020.790

Ejemplares similares